• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Latest research on osteoporosis and bone health at ASBMR 2017 Annual Meeting – Sept. 8-11, Denver

Bioengineer by Bioengineer
August 9, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

With declines in testing, diagnosis and treatment of osteoporosis patients at high risk for fracture, there is an ever growing need for important research and data to help address the treatment gap which has led to a major challenge for public health: a large number of preventable fractures due to osteoporosis.

Thousands of bone scientists will come together for the American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting, the premier scientific meeting in the world on bone, mineral and musculoskeletal science, to present their latest research and collaborate on new opportunities to increase the testing, diagnosis and treatment options.

WHAT: American Society for Bone and Mineral Research Annual Meeting

http://www.asbmr.org/annual-meeting

WHEN: September 8-11, 2017 (Friday to Monday)

WHERE: Colorado Convention Center, Denver, Colorado USA

RSVP: For more information and to register for press credentials, please contact Amanda Darvill at [email protected]

Selected Highlights

Obesity and Fracture Risk: Researchers will present data on predicting fractures in obese patients with Type 2 Diabetes and look at how exercise during weight loss affects the bone density of older adults with obesity.

Heart and Bone: Reduce the Rate of Bone Loss and the Risk of Death? Scientists will share data that suggests that bisphosphonates may actually be protective for cardiovascular disease. The latest results will also be shared from studies in postmenopausal women with osteoporosis that shows a reduction in fracture rates when treated with Romosozumab and Denosumab.

Closing the Treatment Gap: Amid growing evidence that physicians are screening fewer patients for osteoporosis and an alarming number of patients choosing not to follow treatment regimens despite multiple fractures and evidence of osteoporosis, this joint session with ASBMR and the International Osteoporosis Foundation (IOF) will include the release of a new strategic roadmap and recommendations from multiple stakeholders to prevent future fractures in people who have already fractured.

Fracture Liaison Services Saving Lives: Researchers will share data that shows a marked decline in death rates among patients who have suffered a fracture and received fracture liaison services.

Your Aging Cells: Ying and Yang: There is mounting evidence that senescent cells can indeed be both beneficial for tissue repair and regeneration, as well as detrimental, where they can drive the development of multiple age-related diseases. Scientists will share data about a suicide gene stopping senescent cells – found for the first time in bone – thus preventing aging.

What's Next in the Treatment of Osteoporosis? The landscape of pharmacotherapies for osteoporosis has also changed profoundly with the emergence of several potent anti-resorptive drugs as well as new anabolic agents. In spite of these major positive developments, how long patients should remain on these therapies and their long-term safety remain a source of conjecture and concern. Scientists will highlight the latest knowledge and new advances on osteoporosis treatment.

Disease and fracture risk: Scientists present findings on how cancer affects fracture risk from a large study of nearly 100,000 cancer patients. Data will also be shared from a study that suggests that HIV causes higher rates of vertebral fractures.

Testosterone Treatment in Older Men: Researchers will present findings on the effects of testosterone treatment on the bones, physical function and vitality in older men as well as who should be targeted for treatment and safety considerations.

###

For a complete program, please visit http://www.asbmr.org/official-program. Full abstracts are available to all registered media or upon request. For more media information and registration details, please go to http://www.asbmr.org/media or contact Amanda Darvill at [email protected].

The American Society for Bone and Mineral Research (ASBMR) is the leading professional, scientific and medical society established to bring together clinical and experimental scientists involved in the study of bone, mineral and musculoskeletal research. ASBMR encourages and promotes the study of this expanding field through annual scientific meetings, an official journal (Journal of Bone and Mineral Research®), the Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, advocacy and interaction with government agencies and related societies. To learn more about upcoming meetings and publications, please visit http://www.asbmr.org

Media Contact

Amanda Darvill
[email protected]
202-367-2302

http://www.burness.com/

http://www.asbmr.org/annual-meeting

Share14Tweet8Share2ShareShareShare2

Related Posts

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

February 7, 2026

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

February 7, 2026

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

Palmitoylation of Tfr1 Drives Platelet Ferroptosis and Exacerbates Liver Damage in Heat Stroke

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.